Note 3 - Selected Balance Sheet Data (Tables)
|
3 Months Ended |
Sep. 30, 2019 |
|---|
| Notes Tables |
|
| Schedule of Inventory, Current [Table Text Block] |
| |
|
September 30, |
|
|
June 30, |
|
| |
|
2019 |
|
|
2019 |
|
| Raw materials |
|
$ |
41,178 |
|
|
$ |
40,913 |
|
| Finished goods(1) |
|
|
53,044 |
|
|
|
53,376 |
|
| Inventories, net |
|
$ |
94,222 |
|
|
$ |
94,289 |
|
|
| Property, Plant and Equipment [Table Text Block] |
| |
|
September 30, |
|
|
June 30, |
|
| |
|
2019 |
|
|
2019 |
|
| Land |
|
$ |
7,561 |
|
|
$ |
7,065 |
|
| Buildings and improvements |
|
|
175,493 |
|
|
|
175,019 |
|
| Machinery and equipment |
|
|
130,682 |
|
|
|
124,233 |
|
| Property and equipment, cost |
|
|
313,736 |
|
|
|
306,317 |
|
| Accumulated depreciation and amortization |
|
|
(156,953 |
) |
|
|
(152,278 |
) |
| Property and equipment, net |
|
$ |
156,783 |
|
|
$ |
154,039 |
|
|
| Schedule of Intangible Assets and Goodwill [Table Text Block] |
| |
|
September 30, |
|
|
June 30, |
|
| |
|
2019 |
|
|
2019 |
|
| Developed technology |
|
$ |
434,901 |
|
|
$ |
435,679 |
|
| Trade names |
|
|
146,950 |
|
|
|
147,296 |
|
| Customer relationships |
|
|
212,913 |
|
|
|
214,320 |
|
| Patents |
|
|
2,242 |
|
|
|
2,133 |
|
| Intangible assets |
|
|
797,006 |
|
|
|
799,428 |
|
| Accumulated amortization |
|
|
(233,668 |
) |
|
|
(219,999 |
) |
| Intangible assets, net |
|
$ |
563,338 |
|
|
$ |
579,429 |
|
|
| Schedule of Finite-Lived Intangible Assets [Table Text Block] |
| Beginning balance |
|
$ |
579,429 |
|
| Acquisitions |
|
|
- |
|
| Other additions |
|
|
72 |
|
| Amortization expense |
|
|
(14,949 |
) |
| Currency translation |
|
|
(1,214 |
) |
| Ending balance |
|
$ |
563,338 |
|
|
| Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] |
| 2020 remainder |
|
$ |
44,807 |
|
| 2021 |
|
|
59,403 |
|
| 2022 |
|
|
57,804 |
|
| 2023 |
|
|
55,938 |
|
| 2024 |
|
|
53,409 |
|
| Thereafter |
|
|
291,977 |
|
| Total |
|
$ |
563,338 |
|
|
| Schedule of Goodwill [Table Text Block] |
| |
|
Protein Sciences |
|
|
Diagnostics and Genomics |
|
|
Total |
|
| Beginning balance |
|
$ |
377,407 |
|
|
|
355,260 |
|
|
$ |
732,667 |
|
| Acquisitions (Note 4) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Currency translation |
|
|
(2,150 |
) |
|
|
(105 |
) |
|
|
(2,255 |
) |
| Ending balance |
|
$ |
375,257 |
|
|
$ |
355,155 |
|
|
$ |
730,412 |
|
|